‘Benevolent’ patent extensions could raise billions for R&D in poorer countries
Research into vaccines, crop seeds and other innovations for low- or middle-income nations could be rewarded by offering longer patent coverage for profitable, non-essential inventions.
nature.com/articles/d41586-023

The basic idea of a benevolent patent extension is straightforward. An inventor who applies to patent a ‘benevolent discovery’ — one that targets LMICs’ needs — is given the opportunity to offset the R&D costs by extending another patent, for a ‘non-essential’ product. The condition is that the benevolent discovery be offered to the public for unrestricted, non-exclusive, global use, royalty-free for the duration of its patent.

ログインして会話に参加
Fedibird

様々な目的に使える、日本の汎用マストドンサーバーです。安定した利用環境と、多数の独自機能を提供しています。